elastin and Squamous-Cell-Carcinoma-of-Head-and-Neck

elastin has been researched along with Squamous-Cell-Carcinoma-of-Head-and-Neck* in 2 studies

Other Studies

2 other study(ies) available for elastin and Squamous-Cell-Carcinoma-of-Head-and-Neck

ArticleYear
AG-9, an Elastin-Derived Peptide, Increases In Vitro Oral Tongue Carcinoma Cell Invasion, through an Increase in MMP-2 Secretion and MT1-MMP Expression, in a RPSA-Dependent Manner.
    Biomolecules, 2020, Dec-30, Volume: 11, Issue:1

    Oral tongue squamous cell carcinoma is one of the most prevalent head and neck cancers. During tumor progression, elastin fragments are released in the tumor microenvironment. Among them, we previously identified a nonapeptide, AG-9, that stimulates melanoma progression in vivo in a mouse melanoma model. In the present paper, we studied AG-9 effect on tongue squamous cell carcinoma invasive properties. We demonstrated that AG-9 stimulates cell invasion in vitro in a modified Boyen chamber model. It increases MMP-2 secretion, analyzed by zymography and MT1-MMP expression, studied by Western blot. The stimulatory effect was mediated through Ribosomal Protein SA (RPSA) receptor binding as demonstrated by SiRNA experiments. The green tea-derived polyphenol, (-)-epigallocatechin-3-gallate (EGCG), was previously shown to bind RPSA. Molecular docking experiments were performed to compare the preferred areas of interaction of AG-9 and EGCG with RPSA and suggested overlapping areas. This was confirmed by competition assays. EGCG abolished AG-9-induced invasion, MMP-2 secretion, and MT1-MMP expression.

    Topics: Animals; Cell Line, Tumor; Cell Proliferation; Elastin; Gene Expression Regulation, Neoplastic; Humans; Matrix Metalloproteinase 14; Matrix Metalloproteinase 2; Mice; Neoplasm Invasiveness; Peptides; Receptors, Laminin; Ribosomal Proteins; Squamous Cell Carcinoma of Head and Neck

2020
In vivo evaluation of matrix metalloproteinase responsive silk-elastinlike protein polymers for cancer gene therapy.
    Journal of controlled release : official journal of the Controlled Release Society, 2015, Sep-10, Volume: 213

    Silk-elastinlike protein polymers (SELPs) have been effectively used as controlled release matrices for the delivery of viruses for cancer gene therapy in preclinical models. However, the degradability of these polymers needs to be tuned for improved localized intratumoral gene delivery. Using recombinant techniques, systematic modifications in distinct regions of the polymer backbone, namely, within the elastin blocks, silk blocks, and adjacent to silk and elastin blocks, have been made to impart sensitivity to specific matrix metalloproteinases (MMPs) known to be overexpressed in the tumor environment. In this report we investigated the structure-function relationship of MMP-responsive SELPs for viral mediated gene therapy of head and neck cancer. These polymers showed significant degradation in vitro in the presence of MMPs. Their degradation rate was a function of the location of the MMP-responsive sequence in the polymer backbone when in hydrogel form. Treatment efficacy of the adenoviral vectors released from the MMP responsive SELP analogs in a xenograft mouse model of head and neck squamous cell carcinoma (HNSCC) was shown to be polymer structure dependent. These results demonstrate the tunable nature of MMP-responsive SELPs for localized matrix-mediated gene delivery.

    Topics: Adenoviridae; Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; Delayed-Action Preparations; Elastin; Female; Gene Transfer Techniques; Genetic Therapy; Genetic Vectors; Head and Neck Neoplasms; Humans; Matrix Metalloproteinases; Mice, Nude; Silk; Squamous Cell Carcinoma of Head and Neck

2015